Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.660
0.00 (0.00%)
At close: Nov 20, 2026, 4:00 PM EST
2.650
-0.010 (-0.38%)
After-hours: Nov 20, 2026, 7:55 PM EST
Aytu BioPharma Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Aytu BioPharma stock has a consensus rating of "Buy" and an average price target of $8.85. The average 1-year stock price forecast is 232.71% higher than the current stock price, while the lowest is $2.70 (+1.50%) and the highest is $15 (+463.91%).
Price Target: $8.85 (+232.71%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Aytu BioPharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Hold Downgrades $7 | Hold | Downgrades | $7 | +163.16% | Nov 17, 2026 |
| Lake Street | Lake Street | Hold Downgrades $7 → $2.7 | Hold | Downgrades | $7 → $2.7 | +1.50% | Nov 17, 2026 |
| Ascendiant | Ascendiant | Buy Maintains $15 → $15 | Buy | Maintains | $15 → $15 | +463.91% | Sep 29, 2026 |
Financial Forecast
Revenue This Year
70.90M
from 57.57M
Increased by 23.15%
Revenue Next Year
86.91M
from 70.90M
Increased by 22.58%
EPS This Year
-0.37
from -0.83
EPS Next Year
0.16
from -0.37
EPS and Forward PE are based on non-GAAP adjusted numbers.